Melanocortin-4 receptor (MC4R) agonists for the treatment of obesity.
Nargund
Ravi P
RP
Merck Research Laboratories, P.O. Box 2000, Rahway, New Jersey 07065, USA. Ravi_nargund@merck.com
Strack
Alison M
AM
Fong
Tung M
TM
D000818:Animals; D019440:Anti-Obesity Agents / Q000737:chemistry / Q000494:pharmacology* / Q000627:therapeutic use; D001921:Brain / Q000187:drug effects / Q000502:physiology; D015195:Drug Design; D006801:Humans; D008024:Ligands; D008958:Models, Molecular; D009765:Obesity / Q000188:drug therapy*; D009842:Oligopeptides / Q000737:chemistry / Q000494:pharmacology; D044105:Receptor, Melanocortin, Type 4 / Q000819:agonists* / Q000235:genetics / Q000378:metabolism; D012735:Sexual Dysfunction, Physiological / Q000188:drug therapy; D013329:Structure-Activity Relationship; D009435:Synaptic Transmission; D000521:alpha-MSH / Q000737:chemistry / Q000502:physiology
D019440:Anti-Obesity Agents; D008024:Ligands; D009842:Oligopeptides; D044105:Receptor, Melanocortin, Type 4; D000521:alpha-MSH